leadf
logo-loader
viewArcadia Biosciences Inc
(
NASDAQ:RKDA
)

Arcadia Biosciences wins foundational Australian patent covering herbicide tolerance in wheat

The patent grants intellectual property protection for mutations to the wheat genome that make it herbicide tolerant

Arcadia Biosciences Inc - Arcadia Biosciences Inc says Australia Patent Office has granted it a foundational patent covering herbicide tolerance in wheat
The California company is currently soliciting potential licensing partners for its herbicide-tolerant wheat technology

Arcadia Biosciences Inc (NASDAQ:RKDA), which focuses on enhancing the quality and nutritional value of crops and food ingredients, announced Thursday that the Australia Patent Office has granted it a foundational patent covering herbicide tolerance in wheat. 

The patent grants intellectual property protection for mutations to the wheat genome that make it herbicide-tolerant, the company said.

Arcadia Biosciences also received a Notice of Allowance from the US Patent and Trademark Office to cover the same technology. 

READ: Arcadia Biosciences set to enjoy investor attention as it qualifies to join Russell Microcap Index

Australia and the US are the first major wheat-producing countries to approve the patents, with additional patents pending in other key wheat markets, the company said.

"This technology will serve as the foundation for future innovation in herbicide tolerance in wheat," Randy Shultz, chief technology officer at Arcadia Biosciences said in a statement. "With additional research, this technology could also open the door to the development of a highly efficient hybrid wheat production system, which would transform the wheat industry."

Arcadia Biosciences, based in Davis, California, said it is currently soliciting potential licensing partners for its herbicide-tolerant wheat technology.

"This technology can be an important tool in the hybrid breeding toolkit for the right wheat innovator," added Sarah Reiter, the company’s chief commercial officer. 

Arcadia's stock recently traded up by 3.3% to $4.32 a share in New York. 

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

 

 

Quick facts: Arcadia Biosciences Inc

Follow
NASDAQ:RKDA

Price: 2.19 USD

Market Cap: $48.56 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Arcadia Biosciences describes expected synergies with its recent CBD-focused...

Arcadia Biosciences Inc (NASDAQ:RKDA) (FRA:17DN) CEO Matt Plavan describes to Proactive why the group recently acquired CBD-focused Lief Holdings, LLC and Live Zola, LLC. Plavan says in addition to bringing in a 'significant amount of recurring revenue' he sees synergies within the two groups,...

on 05/19/2021

2 min read